uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
QURE Price/Volume Stats
| Current price | $14.87 | 52-week high | $19.18 |
| Prev. close | $14.44 | 52-week low | $4.45 |
| Day low | $14.31 | Volume | 1,219,666 |
| Day high | $15.16 | Avg. volume | 1,421,989 |
| 50-day MA | $14.51 | Dividend yield | N/A |
| 200-day MA | $11.78 | Market Cap | 814.52M |
QURE Stock Price Chart Interactive Chart >
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
QURE Price Returns
| 1-mo | -12.01% |
| 3-mo | 73.51% |
| 6-mo | 7.36% |
| 1-year | 122.94% |
| 3-year | -34.69% |
| 5-year | -67.96% |
| YTD | -15.80% |
| 2024 | 160.86% |
| 2023 | -70.14% |
| 2022 | 9.31% |
| 2021 | -42.60% |
| 2020 | -49.58% |
Continue Researching QURE
Want to see what other sources are saying about uniQure NV's financials and stock price? Try the links below:uniQure NV (QURE) Stock Price | Nasdaq
uniQure NV (QURE) Stock Quote, History and News - Yahoo Finance
uniQure NV (QURE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...